NEW YORK (GenomeWeb) – Agena Bioscience and Molecular Health said today that they have entered into a strategic partnership under which Molecular Health will use its MH Guide analysis platform to interpret raw data generated by Agena's MassArray system.

The relationship is part of Agena's MassArray Insights reporting network, under which the firm seeks to collaborate with various molecular analysis platform providers.

Specific terms of the agreement were not disclosed, but the firms said that they plan to "cooperate and collaborate with their respective customer bases."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.